logo
ENTITY

Dogwood Therapeutics (DWTX US)

5
Analysis
Health Care • United States
Dogwood Therapeutics, Inc. operates as a development-stage biotechnology. The Company develops novel therapeutics and sodium channel blocker to treat moderate-to-severe chemotherapy induced neuropathic pain, cancer pain, and other pain indications. Dogwood Therapeutics serves patients in the United States.
more
Company Event • 05 Apr 2025 01:30 • Upcoming
Add To Calendar

Q4 2024

Company Event • 10 May 2025 00:30 • Upcoming
Add To Calendar

Q1 2025

Company Event • 11 Nov 2024 21:30 • Upcoming
Add To Calendar

Q3 2024

Company Event • 07 Nov 2024 21:30 • Latest

Q3 2024

Company Event • 07 Oct 2024 20:30

M&A Announcement

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.51.2

x